| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net income | ||||||||
809 | 907 | 622 | 644 | 689 | 673 | 0 | 0 | 0 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Amortization and accretion of securities | ||||||||
-24 | -26 | -40 | -14 | -3 | 4 | 0 | 0 | 0 |
Gain on sale of loans held for sale | ||||||||
314 | 215 | 82 | 94 | 136 | 187 | 0 | 0 | 0 |
Originations of loans held for sale | ||||||||
14,358 | 10,385 | 5,727 | 3,886 | 6,120 | 7,314 | 0 | 0 | 0 |
Proceeds from sales of loans held for sale | ||||||||
12,500 | 9,082 | 4,480 | 4,475 | 6,450 | 8,508 | 0 | 0 | 0 |
Gain on sale of available for sale securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Amortization of deferred loan origination costs, net of fees | ||||||||
300 | 267 | 229 | 145 | 93 | 87 | 0 | 0 | 0 |
Provision for loan losses | ||||||||
260 | 175 | 440 | 575 | 590 | 575 | 0 | 0 | 0 |
Increase in accrued interest receivable | ||||||||
-65 | -40 | 113 | 231 | 282 | 169 | 0 | 0 | 0 |
Increase in cash surrender value of life insurance | ||||||||
114 | 114 | 114 | 124 | 124 | 124 | 0 | 0 | 0 |
Depreciation and amortization | ||||||||
153 | 158 | 162 | 164 | 166 | 163 | 0 | 0 | 0 |
ESOP compensation expense | ||||||||
465 | 462 | 0 | 0 | 0 | - | - | - | - |
Stock based compensation expense | ||||||||
0 | - | - | - | - | - | - | - | - |
Deferred income tax benefit | ||||||||
0 | - | - | - | 0 | - | - | - | 0 |
Increase in prepaid expenses and other assets | ||||||||
-56 | -67 | 173 | -169 | -10 | 12 | 0 | 0 | 0 |
Increase in accounts payable and other liabilities | ||||||||
152 | 148 | 106 | 18 | 47 | -108 | 0 | 0 | 0 |
Net cash (used in) provided by operating activities | ||||||||
-105 | 534 | 391 | 2,339 | 1,805 | 2,493 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Net maturities (purchases) of time deposits in other banks | ||||||||
1 | -991 | -4,712 | -4,217 | -3,721 | -1,984 | 0 | 0 | 0 |
Proceeds from maturities, payments and calls of held to maturity securities | ||||||||
- | - | - | - | - | 480 | 0 | 0 | 0 |
Purchases of available for sale securities | ||||||||
- | 17,621 | 0 | 0 | 0 | - | - | - | - |
Proceeds from maturities, payments and calls of available for sale securities | ||||||||
19,254 | 18,610 | 0 | 0 | 0 | - | - | - | - |
Proceeds from Sale of Available-for-sale Securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Purchases of Federal Home Loan Bank stock | ||||||||
450 | 55 | 33 | 33 | 33 | 3 | 0 | 0 | 0 |
Net increase in loans | ||||||||
17,350 | 15,832 | 2,667 | 4,599 | 5,419 | 3,760 | 0 | 0 | 0 |
Proceeds from redemption of bank owned life insurance | ||||||||
- | - | - | - | - | 882 | 0 | 0 | 0 |
Purchases of premises and equipment | ||||||||
60 | 64 | 136 | 140 | 196 | 201 | 0 | 0 | 0 |
Net cash provided by (used in) investing activities | ||||||||
-6,623 | -15,954 | -38,811 | -39,412 | -41,798 | -32,106 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||||
Net increase in deposits | ||||||||
3,548 | 2,690 | -429 | -2,275 | -1,976 | -1,036 | 0 | 0 | 0 |
Net increase in advances by borrowers | ||||||||
77 | 60 | 40 | -127 | -120 | -88 | 0 | 0 | 0 |
Net increase in FHLB advances | ||||||||
0 | - | - | - | - | - | - | - | - |
Repurchase common stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||
8,678 | 2,560 | -2,121 | 34,653 | 35,457 | 36,429 | 0 | 0 | 0 |
Net increase (decrease) increase in cash and cash equivalents | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net (decrease) increase in cash and cash equivalents | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Supplemental disclosure of cash flows information: | ||||||||
Cash paid for interest | ||||||||
1,473 | 1,403 | 1,310 | 1,196 | 1,079 | 977 | 0 | 0 | 0 |
Cash paid for income taxes | ||||||||
190 | 190 | 0 | 0 | 0 | - | - | - | - |